| Literature DB >> 33638805 |
Mrinal K Poddar1, Soumyabrata Banerjee2,3, Apala Chakraborty2, Debasmita Dutta2,4.
Abstract
Alzheimer's disease (AD), a well known aging-induced neurodegenerative disease is related to amyloid proteinopathy. This proteinopathy occurs due to abnormalities in protein folding, structure and thereby its function in cells. The root cause of such kind of proteinopathy and its related neurodegeneration is a disorder in metabolism, rather metabolomics of the major as well as minor nutrients. Metabolomics is the most relevant "omics" platform that offers a great potential for the diagnosis and prognosis of neurodegenerative diseases as an individual's metabolome. In recent years, the research on such kinds of neurodegenerative diseases, especially aging-related disorders is broadened its scope towards metabolic function. Different neurotransmitter metabolisms are also involved with AD and its associated neurodegeneration. The genetic and epigenetic backgrounds are also noteworthy. In this review, the physiological changes of AD in relation to its corresponding biochemical, genetic and epigenetic involvements including its (AD) therapeutic aspects are discussed.Entities:
Keywords: Alzheimer’s disease; Biochemical changes; Genetic changes; Metabolic disorder; Neurodegeneration
Mesh：
Year: 2021 PMID： 33638805 DOI： 10.1007/s11011-021-00673-z
Source DB: PubMed Journal: Metab Brain Dis ISSN： 0885-7490 Impact factor: 3.584